Wisconsin Pharmacal contests Chartex' female condom approval by FDA; firms may merge.
This article was originally published in The Tan Sheet
Executive Summary
WISCONSIN PHARMACAL SEEKS WITHDRAWAL OF CHARTEX' FEMALE CONDOM FDA APPROVAL while Wisconsin Pharmacal is in discussions with Chartex about ways the two firms can collaborate in the global marketing of female condoms, Wisconsin Pharmacal said on Aug. 11. The discussions could result in a merger of the two firms, Wisconsin Pharmacal added.